Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Crespo

Showing results (451-460 of 470) with videos related to

Pageof 47
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repairT R Shenoy, G Boysen, M Y Wang, et al.
Investigational New Drugs|April 30, 2015
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studiesA Omlin, R J Jones, R van der Noll, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 9, 2026
IL-13 promotes accumulation of esophageal epithelial mitochondria with translational implications for eosinophilic esophagitisJazmyne L Jackson, Reshu Saxena, Mary Grace Murray, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 3, 2011
Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosisJ M Diamond, D J Lederer, S M Kawut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2020
A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancerM P Kolinsky, P Rescigno, D Bianchini, et al.
Emerging Microbes & Infections|August 10, 2017
Zika virus replication in the mosquito Culex quinquefasciatus in BrazilDuschinka Rd Guedes, Marcelo Hs Paiva, Mariana Ma Donato, et al.
Annals of the American Thoracic Society|July 19, 2017
Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary HypertensionMary K Porteous, James C Lee, David J Lederer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 8, 2025
Regional differences in primary graft dysfunction: A report from the international consortium on PGDJ Guzman-Bofarull, E Ródenas-Alesina, Y Moayedi, et al.
BMJ Open|June 13, 2024
Scalable Transdiagnostic Early Assessment of Mental Health (STREAM): a study protocolElin H Williams, Nicholas M Thompson, Gareth McCray, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2015
Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction RiskE Cantu, Y Suzuki, J M Diamond, et al.
Pageof 47

Showing results (451-460 of 470) with videos related to

Sort By:
Pageof 47
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repairT R Shenoy, G Boysen, M Y Wang, et al.
Investigational New Drugs|April 30, 2015
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studiesA Omlin, R J Jones, R van der Noll, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 9, 2026
IL-13 promotes accumulation of esophageal epithelial mitochondria with translational implications for eosinophilic esophagitisJazmyne L Jackson, Reshu Saxena, Mary Grace Murray, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 3, 2011
Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosisJ M Diamond, D J Lederer, S M Kawut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2020
A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancerM P Kolinsky, P Rescigno, D Bianchini, et al.
Emerging Microbes & Infections|August 10, 2017
Zika virus replication in the mosquito Culex quinquefasciatus in BrazilDuschinka Rd Guedes, Marcelo Hs Paiva, Mariana Ma Donato, et al.
Annals of the American Thoracic Society|July 19, 2017
Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary HypertensionMary K Porteous, James C Lee, David J Lederer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 8, 2025
Regional differences in primary graft dysfunction: A report from the international consortium on PGDJ Guzman-Bofarull, E Ródenas-Alesina, Y Moayedi, et al.
BMJ Open|June 13, 2024
Scalable Transdiagnostic Early Assessment of Mental Health (STREAM): a study protocolElin H Williams, Nicholas M Thompson, Gareth McCray, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2015
Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction RiskE Cantu, Y Suzuki, J M Diamond, et al.
Pageof 47